AbCellera Biologics Inc. trailing returns
How AbCellera Biologics Inc. (ABCL) has performed over the last day, week, month and year, over 5 years, and since inception, through October 22, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-22. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -7.1% | +0.0% | -7.1% | — |
| 5 days | -10.3% | +0.0% | -10.3% | -10.3%Oct 22 |
| 1 month | -10.1% | +0.0% | -10.1% | -23.3%Oct 22 |
| YTD | +232.5% | +0.0% | +232.5% | -40.1%Feb 5 |
| 1 year | +107.9% | +0.0% | +107.9% | -51.8%Feb 2026 |
| 5 years | -6.6% | +0.0% | -6.6%-28.8% | -89.1%Apr 2025 |
| Since inception (2020) | -24.5% | +0.0% | -24.5%-80.7% | -96.7%Apr 2025 |
Growth of ABCL#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-6.6%/year · -28.8%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-22). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in ABCL's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is AbCellera Biologics Inc.'s return since inception?
- Since 2020, AbCellera Biologics Inc. (ABCL) has compounded at about -24.5% a year — -80.7% in total.